Osteosarcoma is a cancerous (malignant) bone tumor that usually develops during the period of rapid growth that occurs in adolescence, as a teenager matures into an adult.
Osteosarcoma is the most common cancerous (malignant) bone tumor in kids. The average age at diagnosis is 15. Boys and girls are just as likely to get this tumor until the late teen years, when it is more often seenin boys. Osteosarcoma is also more commonly seen in people over age 60.
The cause is not known. In some cases, osteosarcoma runs in families. At least one gene has been linked to an increased risk. This gene is also associated with familial retinoblastoma, a cancer of the eye that occurs in children.
Osteosarcoma tends to occur in the bones of the:
This cancer occurs most commonly in larger bones and in the area of bone with the fastest growth rate. Osteosarcoma can occur in any bone, however.
Treatment usually starts after a biopsy of the tumor is done.
Before major surgery to remove the tumor, chemotherapy is usually given. This can shrink the tumor and it makes surgery easier. It also may kill any cancer cells that have spread to other parts of the body.
Chemotherapy medicines include:
Surgery is used after chemotherapy to remove any remaining tumor. In most cases, surgery can remove the tumor while saving the affected limb (this is called limb-salvage surgery). Rarely, more radical surgery (such as amputation) may be necessary.
Association of Cancer Online Resources -- www.acor.org
Cure Search for Children's Cancer --www.curesearch.org
If the tumor has not spread to the lungs (pulmonary metastasis), long-term survival rates are better. If the cancer has spread to other parts of the body, the outlook is worse. However, there is still a chance of cure with effective treatment.
Call your health care provider if you have persistent bone pain, tenderness, or swelling.
Lerner A, Antman KH. Primary and metastatic malignant bone lesions. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, PA: Saunders Elsevier; 2011:chap 208.
National Cancer Institute. Osteosarcoma and malignant fibrous histiocytoma of bone treatment PDQ. Updated October 12, 2011.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bone Cancer. Version 2.2011.